Future Directions for Vascular Access for Hemodialysis

Seminars in Dialysis

Volumn 28, Issue 2, 2015, Pages 107-113

  Roy Chaudhury, Prabir ^a   Kruska, Lindsay ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTERIOVENOUS SHUNT; DEVICES; HUMAN; INDWELLING CATHETER; KIDNEY FAILURE, CHRONIC; RENAL REPLACEMENT THERAPY; STANDARDS; TRENDS;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; HUMANS; KIDNEY FAILURE, CHRONIC; RENAL DIALYSIS;

EID: 84924591046     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/sdi.12329     Document Type: Article

References (56)

1. US Renal Data System: USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2013
2. US Renal Data System: USRDS 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 2011
3. Allon M, Robbin M: Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 62:1109-1124, 2002
4. Lok C, Sontrop J, Tomlinson G, Rajan D, Cattral M, Oreopoulos G, Harris J, Moist L: Cumulative patency of contemporary fistulas versus grafts (2000-2010). Clin J Am Soc Nephrol 8:810-818, 2013
5. Dember L, Beck G, Allon M, Delmez J, Dixon B, Greenberg A, Himmelfarb J, Vazquez M, Gassman J, Greene T, Radeva M, Braden G, Ikizler T, Rocco M, Davidson I, Kaufman J, Meyes C, Kusek J, Feldman H: Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 18:2164-2171, 2008
6. Roy-Chaudhury P, Sukhatme V, Cheung A: Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint. J Am Soc Nephrol 17:1112-1127, 2006
7. Dixon B, Beck G, Vazquez M, Greenburg A, Delmez J, Allon M, Dember L, Himmelfarb J, Gassman J, Greene T, Radeva M, Davidson I, Ikizler T, Braden G, Fenves A, Kaufman J, Cotton J, Martin K, McNeil J, Rahman A, Lawson J, Whiting J, Hu B, Meyes C, Kusek J, Feldman H: Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 360:2191-2201, 2009
8. Lee T, Chauhan V, Krishnamoorthy M, Wang Y, Arend L, Mistry M, El-Khatib M, Banerjee R, Munda R, Roy-Chaudhury P: Severe venous neointimal venous hyperplasia prior to dialysis access surgery. Nephrol Dial Transplant 26:2264-2270, 2011
9. Allon M, Robbin ML, Young CJ, Deierhoi MH, Goodman J, Hanaway M, Lockhart ME, Litovsky S: Preoperative venous intimal hyperplasia, postoperative arteriovenous fistula stenosis, and clinical fistula outcomes. Clin J Am Soc Nephrol 8:1750-1755, 2013
10. Roy-Chaudhury P, Arend L, Zhang J, Krishnamoorthy M, Wang Y, Banerjee R, Samaha A, Munda R: Neointimal hyperplasia in early arteriovenous fistula failure. Am J Kidney Dis 50:782-790, 2007
11. Roy-Chaudhury P, Wang Y, Krishnamoorthy M, Zhang J, Banerjee R, Munda R, Heffelfinger S, Arend L: Cellular phenotypes in human stenotic lesions from haemodialysis vascular access. Nephrol Dial Transplant 24:2786-2791, 2009
12. Roy-Chaudhury P, Kelly B, Miller M, Reaves A, Armstrong J, Nanayakkara N, Heffelfinger S: Venous neointimal hyperplasia in polytetrafluoroethylene dialysis grafts. Kidney Int 59:2325-2334, 2001
13. Chiu J, Chien S: Effects of disturbed flow on vascular endothelium: pathophysiologic basis and clinical perspectives. Physiol Rev 91:327-387, 2011
14. Ene-Iordache B, Remuzzi A: Disturbed flow in radial-cephalic arteriovenous fistulae for haemodialysis: low and oscillating shear stress locates the site of stenosis. Nephrol Dial Transplant 27:358-368, 2012
15. Ene-Iordache B, Cattaneo L, Dubini G, Remuzzi A: Effect of anastomosis angle on the localization of disturbed flow in 'side-to-end' fistulae for hemodialysis access. Nephrol Dial Transplant 28:1005-1012, 2013
16. Remuzzi A, Ene-Iordache B: Novel paradigms for dialysis vascular access: upstream hemodynamics and vascular remodelling in dialysis access stenosis. Clin J Am Soc Nephrol 8:2186-2193, 2013
17. Remuzzi A, Ene-Iordache B, Mosconi L, Bruno S, Anghileri A, Antiga L, Remuzzi G: Radial artery wall shear stress evaluation in patients with arteriovenous fistula for hemodialysis access. Biorheology 40:423-430, 2003
18. Mezzano D, Pais EO, Aranda E, Panes O, Downey P, Ortiz M, Tagle R, Gonzalez F, Quiroga T, Caceres MS, Leighton F, Pereira J: Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia. Kidney Int 60:1844-1850, 2001
19. Kang L, Yamada S, Hernandez MC, Croatt AJ, Grande JP, Juncos JP, Vercellotti GM, Hebbel RP, Katusic ZS, Terzic A, Nath KA: Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula. Am J Physiol Renal Physiology 301:F845-F851, 2011
20. Lin C, Yang W, Lin S, Chen T, Lee W, Chang C, Lee P, Lee S, Su T, Fann C, Chung M: Length polymorphisms in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients. Kidney Int 69:165-172, 2006
21. Juncos J, Tracz M, Croatt A, Grande J, Ackerman A, Katusic Z, Nath K: Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse. Kidney Int 74:47-51, 2008
22. Juncos J, Grande J, Kang L, Ackerman A, Croatt A, Katusic Z, Nath K: MCP-1 contributes to arteriovenous fistula failure. J Am Soc Nephrol 22:43-48, 2011
23. Daly C, Rollins B: Monocyte chemoattractant protein-1 (CCL2) in inflammatory diseases and adaptive immunity: therapeutic opportunities and controversies. Microcirculation 10:247-257, 2003
24. Charo I, Ransohoff R: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610-621, 2006
25. Schepers A, Eefting D, Bonta P, Grimbergen J, deVries M, van. Weel V, deVries C, Egashira K, von Bockel J, Quax P: Anti-MCP-1 gene therapy inhibits vascular smooth muscle cells proliferation and attenuates vein graft thickening both in vitro and in vivo. Arterioscler Thromb Vasc Biol 26:2063-2069, 2006
26. Tronc F, Mallat Z, Lehoux S, Wassef M, Esposito B, Tedgui A: Role of matrix metalloproteinases in blood flow-induced arterial enlargement: Interaction with NO. Arterioscler Thromb Vasc Biol 20:E120-E126, 2000
27. Bendeck MP, Zempo N, Clowes AW, Galardy RE, Reidy MA: Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ Res 75:539-545, 1994
28. Campos B, Lee T, Roy-Chaudhury P: Arteriovenous fistula failure: is there a role for epigenetic regulation. Semin Nephrol 33:400-406, 2013
29. Yan MS, Matouk C, Marsden PA: Epigenetics of the vascularendothelium. J Appl Physiol 26:916-926, 2010
30. Lee T, Ullah A, Allon M, Succop P, El-Khatib M, Munda R, Roy-Chaudhury P: Decreased cumulative survival in arteriovenous fistulas requiring interventions to promote maturation. Clin J Am Soc Nephrol 6:575-581, 2011
31. Chang C, Ko P, Hsu L, Ko YS, Ko YL, Chen C, Huang C, Hsu T, Lee Y, Pang J: Highly increased cell proliferation activity in the restenotic hemodialysis vascular access after percutaneous transluminal angioplasty: implication in prevention of restenosis. Am J Kidney Dis 43:74-84, 2004
32. Talas U, Dunlop J, Khalaf S, Leigh IM, Kelsell DP: Human elastase 1: evidence for expression in the skin and the identification of a frequent frameshift polymorphism. J Invest Dermatol 114:165-170, 2000
33. Tani T, Kawashima I, Furukawa H, Ohmine T, Takiguchi Y: Characterization of a silent gene for human pancreatic elastase I: structure of the 5′-flanking region. J Biochem 101:591-599, 1987
34. Dobrin PB, Canfield TR: Elastase, collagenase, and the biaxial lastic properties of dog carotid artery. Am J Physiol 247:H124-H13, 1984
35. Qamar AA, Burke SK, Lafleur JD, Ding BC, Bland KS, Wong MD, Gustafson PN, Blair AT, Franano FN: The ability of serum from alpha 1-antitrypsin-deficient patients to inhibit PRT-201, a recombinant human type I pancreatic elastase. Biotechnol Appl Biochem 59:22-28, 2012
36. Hance KA, Franano FN, Henry C, et al.: Prot-101 dilates AV fistula (AVF) outflow veins and reduces intimal hyperplasia in a rabbit model. J Am Soc Nephrol 16:11A, 2005
37. Franano FN, Hance K, Bland KS, Burke SK: PRT-201 dilates outflow veins and improves maturation rates in a rabbit model of AVF. Nephrol Dial Transplant 22:vi155-vi156, 2007
38. Peden E, Leeser D, Dixon B, El-Khatib M, Roy-Chaudhury P, Lawson J, Menard M, Dembar L, Glickman M, Gustafson P, Blair A, Magill M, Franano F, Burke S: A multi-center, dose-escalation study of human type 1 pancreatic elastase (PRT-201) administered after arteriovenous fistula creation. J Vasc Access 14:143-151, 2013
39. Dwivedi A, Roy-Chaudhury P, Peden E, Browne B, Ladenheim E, Scavo V, Gustafson P, Wong M, Magill M, Lindow F, Blair A, Jaff M, Franano N, Burke S: Application of human type I pancreatic elastase (PRT-201) to the venous anastomosis of arteriovenous grafts in patients with chronic kidney disease. J Vasc Access 15:376-384, 2014
40. Katsanos K, Karnabatidis D, Kitrou P, Spiliopoulos S, Christeas N, Siablis D: Paclitaxel-coated balloon angioplasty vs. plain balloon dilation for the treatment of failing dialysis access: 6-month interim results from a prospective randomized controlled trial. J Endovasc Ther 19:263-272, 2012
41. Conte M, Nugent H, Gaccione P, Guleria I, Roy-Chaudhury P, Lawson J: Multicenter phase I/II trial of the safety of allogeneic endothelial cell implants after the creation of arteriovenous access for hemodialysis use: the V-HEALTH study. J Vasc Surg 50:1359-1368, 2009
42. Bharat A, Jaenicke M, Shenoy S: A novel technique of vascular anastomosis to prevent juxta-anastamotic stenosis following arteriovenous fistula creation. J Vasc Surg 55:274-280, 2012
43. Roy-Chaudhury P, Want Y, Krishnamoorthy M, Dakin A: Optiflow: a novel anastmotic conduit for reducing av fistula dysfunction. J Am Soc Nephrol 19:253A, 2008
44. Manson R, Ebner A, Gallo S, Chemla E, Mantell M, Deaton D, Roy-Chaudhury P: Arteriovenous fistula creation using the optiflow vascular anastomosis device: a first in man pilot study. Semin Dial 26:97-99, 2013
45. Imamura M, Biro S, Kihara T, Yoshifuku S, Takasaki K, Otsuji Y, Minagoe S, Toyama Y, Tei C: Repeated thermal therapy improves impaired vascular endothelial function in patients with coronary risk factors. J Am Coll Cardiol 38:1083-1088, 2001
46. Lin CC, Chang CF, Lai MY, Chen TW, Lee PC, Yang WC: Far-infrared therapy: a novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients. J Am Soc Nephrol 18:985-992, 2007
47. Lin C, Yang W, Chen M, Liu W, Yang C, Lee P: Effect of Far infrared therapy on arteriovenous fistula maturation: an open label randomized controlled trial. Am J Kidney Dis 62:304-311, 2013
48. Kiyama H, Imazeki T, Kurihara S, Yoneshima H: Long-term follow up of polyurethane vascular grafts for hemoaccess bridge fistulas. Ann Vasc Surg 17:516-521, 2003
49. Palumbo R, Niscola P, Calabria S, Fierimonte S, Bevilacqua M, Scaramucci L, Tolu B, Fabritiis P, Bondanini F: Long-term favorable results by arteriovenous graft with omniflow II prosthesis for hemodialysis. Nephron Clin Pract 113:c76-c80, 2009
50. Wang SS, Chu SH: Clinical use of omniflow vascular graft as arteriovenous bridging graft for hemodialysis. Artif Organs 20:1278-1281, 1996
51. Manson R, Unger J, Ali A, Gage S, Lawson J: Tissue-Engineered vascular grafts: autologous off-the-shelf vascular access? Semin Nephrol 32:582-591, 2012
52. Krawiec J, Vorp D: Adult stem cell-based tissue engineered blood vessels: a review. Biomaterials 33:3388-3400, 2012
53. Ebner A, Gallo S, Cetraro C, Gurley J, Minarsch L: Inside-out upper body venous access. Endovasc Today 85-89, June 2013.
54. Allon M, Bailey R, Ballard R, Deierhoi M, Hamrick K, Oser R, Rhynes V, Robbin M, Saddekni S, Zeigler S: A multidisciplinary approach to hemodialysis access: prospective evaluation. Kidney Int 53:473-479, 1998
55. Dwyer A, Shelton P, Brier M, Aronoff G: A vascular access coordinator improves the prevalent fistula rate. Semin Dialysis 25:239-243, 2012
56. Peters V, Crooks P, Rutkowski M, Cairoli O: Vascular access management: ongoing challenges and strategies for success. Nephrol News Issues 28:26, 28, 30-33, 2014